Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil Scientific literature GHDx Entry last modified on: Jun 17, 2021
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia Scientific literature GHDx Entry last modified on: Jun 17, 2021
Canada - COVID-19 Data in Quebec 2020 Données COVID-19 au Québec Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Scotland Enhanced Surveillance of Covid-19 Dashboard 2020-2022 Enhanced Surveillance of Covid-19 in Scotland (Population-based seroprevalence) Epi surveillance: Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Brazil - Rio Grande Do Sol Prevlanece Research - Epicovid19 Study 2020 - Phases 1-8 Epicovid19 study Phases 1-8 Survey: Epi surveillance GHDx Entry last modified on: May 15, 2024
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades Scientific literature GHDx Entry last modified on: Mar 14, 2022
Spain - National Study of Sero-epidemiology of Infection by Sars-Cov-2 2020 Estudio Nacional de Sero-epidemiología de la Infección por Sars-Cov-2 en España Survey: Exam - Household - Interview - Longitudinal GHDx Entry last modified on: Aug 24, 2023
Estonia COVID-19 Coronavirus prevalence study 2020-2023 Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire" Survey: Epi surveillance GHDx Entry last modified on: Aug 28, 2023
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
CDC COVID Data Tracker Commercial Laboratory Seroprevalence Survey Data 2020-2022 Survey: Epi surveillance - Individual - Subnationally representative GHDx Entry last modified on: Aug 24, 2023
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021 COVID-19 Public Seroprevalence Report April 2020 to January 2021 Epi surveillance: Nationally representative GHDx Entry last modified on: May 13, 2024
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Denmark Blood Donors are Now Being Re-examined for Coronavirus Infection Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
England - Coronavirus (COVID-19) Infection Survey: Antibody Data, January 2021 Coronavirus (COVID-19) Infection Survey: antibody data for the UK, January 2021 Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
A COVID-19 Hotspot Area: Activities and Epidemiological Findings Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline Scientific literature GHDx Entry last modified on: May 12, 2022
France Covid-19 Information - Average number of new daily hospitalizations 2020-2022 Informations Covid-19 - Nombre moyen de nouvelles hospitalisations quotidiennes Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Brazil - Government of Espírito Santo COVID-19 Serological Survey 2020 Coronavírus - Inquérito Sorológico Survey GHDx Entry last modified on: Aug 29, 2023
France COVID-19 Epidemic Monitoring Dashboard 2020-2022 Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Belgium Prevalence of anti-SARS-CoV-2 antibodies (IgG) among blood donors 2020-2021 Belgium COVID-19 Studies, Seroprevalence in Blood Donors Epi surveillance GHDx Entry last modified on: Aug 24, 2023
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series 2020-2022 Epi surveillance: Health facility - Subnationally representative GHDx Entry last modified on: Aug 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? Scientific literature GHDx Entry last modified on: Mar 14, 2022
India COVID-19 Official Government of India updates - Twitter 2020-2022 Epi surveillance GHDx Entry last modified on: Aug 28, 2023
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Canada COVID-19 Seroprevalence Report - January 12, 2021 COVID-19 Seroprevalence Report January 12, 2021 - Report #4: November 2020 Survey Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Canada COVID-19 Seroprevalence Report - December 18, 2020 COVID-19 Seroprevalence Report December 18, 2020 - Report #3: October 2020 Survey Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2) Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Germany - Saarland antibody study on coronavirus infection completed: Institute for Virology at Saarland University Hospital presents results Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Switzerland COVID-19 PCR Antigen Tests by Region 2020 Daily record timelines by geoRegion and test type (pcr/antigen) for testsonen Epi surveillance: Subnationally representative GHDx Entry last modified on: May 12, 2022
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint. Scientific literature GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany Scientific literature GHDx Entry last modified on: Jan 31, 2024
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo Scientific literature GHDx Entry last modified on: Jan 31, 2024
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada Scientific literature GHDx Entry last modified on: May 12, 2022
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint Scientific literature: Cross-sectional GHDx Entry last modified on: May 12, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China Scientific literature GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022